Tonix Pharmaceuticals Holding Corp. - TNXP

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A Sirenia Capital Management LP 4.9% 814,801 View
Aug 14, 2026 SCHEDULE 13G/A Alex Silverstein 4.9% 814,801 View
Aug 13, 2026 SCHEDULE 13G AQR Capital Management, LLC 5.54% 882,595 View
Aug 13, 2026 SCHEDULE 13G AQR Capital Management Holdings, LLC 5.54% 882,595 View
Jun 15, 2026 SCHEDULE 13G Millennium Management LLC 5.6% 890,366 View
Jun 15, 2026 SCHEDULE 13G Millennium Group Management LLC 5.6% 890,366 View
Jun 15, 2026 SCHEDULE 13G Israel A. Englander 5.6% 890,366 View
May 15, 2026 SCHEDULE 13G/A Point72 Asset Management, L.P. 6.9% 1,100,964 View
May 15, 2026 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 6.9% 1,100,964 View
May 15, 2026 SCHEDULE 13G/A Steven A. Cohen 6.9% 1,100,964 View
May 15, 2026 SCHEDULE 13G Sirenia Capital Management LP 8.8% 1,297,470 View
May 15, 2026 SCHEDULE 13G Alex Silverstein 8.8% 1,297,470 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.